Answer
The safety and efficacy of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead have not been established in children under 18 years, and no dosing recommendation can be made.
Sources for this answer
- Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead 200 mg/25 mg/245 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.2 Posology and method of administration · Version 33Document updated
Sources checked